Product overview

Name FH 535
Purity >99%
Description Wnt/β-catenin inhibitor and PPARγ/δ antagonist.
Write Your Own Review
You're reviewing:FH 535
Rate this item:

Biological Data

Biological description Wnt/β-catenin inhibitor and PPARγ/δ antagonist. Reduces NO production. Shows antiproliferative and anti-cancer actions.

Solubility & Handling

Storage instructions +4°C
Solubility overview Soluble in DMSO (75mM)
Important This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use.

Calculators

Molarity

=
x
x
More Info

Dilution

x
=
x
More Info

Chemical Data

Purity >99%
Chemical name 2,5-Dichloro-N-(2-methyl-4-nitrophenyl)benzenesulfonamide
Molecular Weight 361.2
Chemical structure FH 535  [108409-83-2] Chemical Structure
Molecular Formula C13H10Cl2N2O4S
CAS Number 108409-83-2
PubChem identifier 3463933
SMILES ClC1=CC(S(NC2=C(C)C=C([N+]([O-])=O)C=C2)(=O)=O)=C(Cl)C=C1
InChiKey AXNUEXXEQGQWPA-UHFFFAOYSA-N

References for FH 535

References are publications that support the biological activity of the product
  • FH535 inhibits the proliferation of HepG2 cells via downregulation of the Wnt/β-catenin signaling pathway.

    Liu J et al (2014) Mol Med Rep 9(4) : 1289-92.
  • Targeting the Wnt/β-catenin signaling pathway in liver cancer stem cells and hepatocellular carcinoma cell lines with FH535.

    Gedaly R et al (2014) PLoS One 9(6) : e99272.
  • A small-molecule inhibitor of Tcf/beta-catenin signaling down-regulates PPARgamma and PPARdelta activities.

    Handeli S et al (2008) Mol Cancer Ther 7(3) : 521-9.

3 Item(s)